<DOC>
	<DOCNO>NCT03035500</DOCNO>
	<brief_summary>This clinical trial study well long-term follow-up work patient prostate cancer surgery . Long-term follow-up data may serve resource help ask clinical question , describe health-related quality life long-term complication relate , facilitate future study focus intervention improve health status health-related quality life prostate cancer survivor .</brief_summary>
	<brief_title>Long-Term Follow-Up Patients With Prostate Cancer After Surgery</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To provide comprehensive long-term follow-up care prostate cancer survivor City Hope underwent definitive surgical therapy . II . To use information obtain follow-up prostate cancer survivor underwent definitive surgical therapy serve resource help answer clinical question , generate test hypothesis , describe incidence long-term complication , facilitate future study focus intervention long-term complication prostate cancer therapy . III . To use information gain follow-up prostate cancer survivor underwent definitive surgical therapy describe health-related quality life ( HRQL ) concern serve resource facilitate future study focus intervention improve health status HRQL prostate cancer survivor . OUTLINE : Patients undergo long-term follow-up receive write survivorship care plan include comprehensive health evaluation health education begin 1 year post surgery .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Diagnosis prostate cancer Treated definitive surgical procedure City Hope At least one year post surgical treatment prostate cancer No history recurrent , progressive , metastatic disease Currently stable disease evidence disease No prior treatment prostate cancer radiation chemotherapy No history urologic cancer ( e.g. , bladder cancer , renal cell carcinoma ) addition prostate cancer Note : Patients develop recurrence participate Prostate Cancer Survivorship Clinic refer back urologist may resume participation Survivorship Clinic deem appropriate treating physician Current treatment testosterone replacement androgen deprivation therapy Treatment another noncutaneous cancer within past 2 year</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>